Ultragenyx Pharmaceutical must file required documents regarding its NASDAQ company status with the SEC.
1 report, 1 independent
Updated Jul 3
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Ultragenyx Pharmaceutical must file required documents regarding its NASDAQ company status with the SEC.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Ultragenyx Pharmaceutical
biopharmaceutical company based in Novato, California, United States
Nothing else this week.
-
Securities and Exchange Commission
government agency of the Philippines
Related events
- The Ensign Group, Inc. filed required documents with the SEC and was listed on the Nasdaq stock exchange.
- Vaxcyte, Inc. filed required documents with the SEC and traded on the NASDAQ exchange.
- BioLineRx Ltd. is utilizing the Nasdaq stock exchange for a registered direct offering, filing with the SEC.
- CalciMedica, Inc. is seeking to maintain its listing requirements on NASDAQ by filing required corporate action documents with the SEC.
- Silicon Laboratories stock traded on Nasdaq and required SEC filings on September 8, 2026.